Literature DB >> 8770721

Cost of hypertension treatment.

T W Odell1, M C Gregory.   

Abstract

A retrospective analysis was conducted of the cost of hypertension care at one internal medicine clinic, looking at the cost of office visits, laboratory tests, and medications. Cost of hypertension care was $947 the first year of treatment, $575 the second year, and $420 per year thereafter. Drug costs were the major determinant of cost of care, comprising 80% of the total cost of treatment after the first year of therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8770721     DOI: 10.1007/bf02602764

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

1.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

2.  The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

Authors: 
Journal:  Arch Intern Med       Date:  1993-01-25

3.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

4.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

5.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.

Authors:  J D Neaton; R H Grimm; R J Prineas; J Stamler; G A Grandits; P J Elmer; J A Cutler; J M Flack; J A Schoenberger; R McDonald
Journal:  JAMA       Date:  1993-08-11       Impact factor: 56.272

6.  Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

Authors:  A Helgeland
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

7.  Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.

Authors:  D E Hilleman; S M Mohiuddin; B D Lucas; J A Stading; A M Stoysich; K Ryschon
Journal:  Clin Ther       Date:  1994 Jan-Feb       Impact factor: 3.393

8.  Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.

Authors:  C A Silagy; J J McNeil; B P McGrath
Journal:  Am J Cardiol       Date:  1992-11-15       Impact factor: 2.778

9.  Coronary heart-disease after treatment of hypertension.

Authors:  G Berglund; R Sannerstedt; O Andersson; H Wedel; L Wilhelmsen; L Hansson; R Sivertsson; J Wikstrand
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

10.  The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

Authors: 
Journal:  Lancet       Date:  1980-06-14       Impact factor: 202.731

View more
  8 in total

1.  Cost of hypertension treatment.

Authors:  J S Ahluwalia; J P Doyle
Journal:  J Gen Intern Med       Date:  1996-04       Impact factor: 5.128

2.  Choosing antihypertensive therapy.

Authors:  D A Katzman; B Littenberg
Journal:  J Gen Intern Med       Date:  1995-12       Impact factor: 5.128

3.  Are we operating too late? Mortality Analysis and Stochastic Simulation of Costs Associated with Bariatric Surgery: Reconsidering the BMI Threshold.

Authors:  Ashish C Sinha; Preet Mohinder Singh; Suneel Bhat
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

4.  Lifetime health and economic benefits of weight loss among obese persons.

Authors:  G Oster; D Thompson; J Edelsberg; A P Bird; G A Colditz
Journal:  Am J Public Health       Date:  1999-10       Impact factor: 9.308

5.  The impact of morbid obesity on resource utilization after renal transplantation.

Authors:  Young Kim; Alex L Chang; Koffi Wima; Audrey E Ertel; Tayyab S Diwan; Daniel E Abbott; Shimul A Shah
Journal:  Surgery       Date:  2016-08-26       Impact factor: 3.982

6.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190

7.  Revisiting rose: comparing the benefits and costs of population-wide and targeted interventions.

Authors:  Jennifer Ahern; Matthew R Jones; Erin Bakshis; Sandro Galea
Journal:  Milbank Q       Date:  2008-12       Impact factor: 4.911

8.  Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.

Authors:  Akihiko Ozaki; Hiroaki Saito; Yosuke Onoue; Toyoaki Sawano; Yuki Shimada; Yurie Somekawa; Aritsune Tsuji; Tetsuya Tanimoto
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.